Cargando…
Neutrophils and Macrophages as Targets for Development of Nanotherapeutics in Inflammatory Diseases
Neutrophils and macrophages are major components of innate systems, playing central roles in inflammation responses to infections and tissue injury. If they are out of control, inflammation responses can cause the pathogenesis of a wide range of diseases, such as inflammatory disorders and autoimmun...
Autores principales: | Su, Yujie, Gao, Jin, Kaur, Puneet, Wang, Zhenjia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766591/ https://www.ncbi.nlm.nih.gov/pubmed/33348630 http://dx.doi.org/10.3390/pharmaceutics12121222 |
Ejemplares similares
-
Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites
por: Dong, Xinyue, et al.
Publicado: (2017) -
Imaging Nanotherapeutics in Inflamed Vasculature by Intravital Microscopy
por: Wang, Zhenjia
Publicado: (2016) -
Liposomal Formulations Enhance the Anti-Inflammatory Effect of Eicosapentaenoic Acid in HL60 Cells
por: Kaur, Puneet, et al.
Publicado: (2022) -
Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease
por: Liu, Ping, et al.
Publicado: (2021) -
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus
por: Majumder, Joydeb, et al.
Publicado: (2020)